Women's Health Devices Global Market Report 2024

Women's health devices encompass a range of tools designed to empower women in managing their health and related data through at-home tests and other features. These devices play a crucial role in enhancing women's healthcare across various aspects, including maternal and menstrual health, pelvic and sexual health, fertility, menopause, contraception, and addressing general health disorders that may affect women differently or disproportionately, such as osteoporosis or cardiovascular disease.

The main types of women's health devices include surgical, diagnostics, contraceptives, labor and delivery, and critical care. Surgical devices are specialized tools used by surgeons to address specific medical conditions. The applications of women's health devices cover areas such as cancer, osteoporosis, infectious diseases, uterine fibroids, post-menopausal syndrome, pregnancy, female sterilization, and more. Various end-users, including hospitals, obstetrics and gynecology clinics, diagnostic laboratories, ambulatory surgical centers, and other healthcare facilities, utilize these devices.

The women’s health devices market research report is one of a series of new reports that provides women’s health devices market statistics, including women’s health devices industry global market size, regional shares, competitors with a women’s health devices market share, detailed women’s health devices market segments, market trends and opportunities, and any further data you may need to thrive in the women’s health devices industry. This women’s health devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The women’s health devices market size has grown rapidly in recent years. It will grow from $37.68 billion in 2023 to $41.64 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The expansion observed in the historical period in the women's health devices market can be attributed to factors such as an increase in awareness about women's health and well-being, a rise in the prevalence of women-specific health issues, the expansion of healthcare infrastructure, an increase in disposable income, and a rise in healthcare spending. These factors collectively contributed to the growth of the women's health devices market during the historic period.

The women’s health devices market size is expected to see rapid growth in the next few years. It will grow to $63.07 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The anticipated growth in the forecast period in the women's health devices market can be attributed to factors such as supportive government initiatives, changing lifestyles and dietary habits, the expanding geriatric female population, ongoing research and development efforts, and an increasing focus on personalized medicine. Major trends expected in the forecast period include the adoption of wearable women's health devices, the integration of telemedicine and remote monitoring solutions, the incorporation of artificial intelligence (AI) and machine learning, a preference for non-invasive and minimally invasive procedures, and the development of menopause management solutions.

The women's health devices market is experiencing growth due to an increase in government programs aimed at raising awareness about women's health. These initiatives involve organizing events and campaigns to enhance public awareness of various societal issues, contributing to the efficiency of the public healthcare system. Such government programs play a crucial role in creating awareness, leading to a heightened demand for women's health devices for easier diagnosis. An illustrative example is the Victorian government's release of its inaugural women's sexual and reproductive health strategy in March 2022, supported by a $6.6 million investment to address issues, reduce stigma, and enhance knowledge of sexual and reproductive health.

The rising incidence of chronic diseases is also a significant driver of the women's health devices market. Chronic diseases, enduring medical conditions lasting three months or more, are prevalent globally. Women's health devices cater specifically to the unique physiological needs of females, aiding in early detection, continuous monitoring, and effective management of chronic diseases. According to the World Health Organization's data from September 2022, non-communicable diseases (NCDs) account for 74% of global deaths annually, highlighting the urgency for effective healthcare solutions targeting chronic diseases like cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes.

A noteworthy trend in the women's health devices market is technological advancement. Companies within this sector are actively seeking innovative technologies to strengthen their market position. For instance, iSono Health launched ATUSA in May 2022, representing the world's first portable and automated 3D breast ultrasound scanner. Combining a unique 3D ultrasound scanner with artificial intelligence, ATUSA facilitates full breast scans, accurately locating breast tumors. This technological advancement demonstrates a commitment to advancing healthcare solutions for women.

Major players in the women's health devices market are introducing smart rings to provide women with medical-grade health data, translating into personalized insights. Smart rings designed for women deliver health metrics, including heart rate, SpO2, menstrual tracking, and sleep data, through a mobile app. Movano Health's Evie, launched in January 2023, is a women-specific smart ring adhering to FDA regulatory standards, capturing diverse health metrics and presenting them in an easily understandable format on the accompanying app.

In February 2022, CooperSurgical, a prominent women's healthcare brand, acquired Cook Medical's reproductive health portfolio for $875 million. This strategic acquisition by both companies aims to foster future growth and introduce new technologies. Cook Medical, known for manufacturing invasive medical devices for fertility, obstetrics, gynaecology, in vitro fertilization, and assisted reproductive technology, aligns with CooperSurgical's objectives in the women's healthcare sector.

Major companies operating in the women’s health devices market include Abbott Laboratories, Koninklijke Philips N.V., CooperSurgical Inc., F. Hoffmann-La Roche Ltd., Caldera Medical Inc., Medtronic PLC, Johnson & Johnson, GE HealthCare Technologies Inc., Siemens Healthineers AG, Hologic Inc., Boston Scientific Corporation, Cardinal Health Inc., Becton, Dickinson and Company, Olympus Corporation, Fujifilm Holdings Corporation, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Intuitive Surgical Inc., Merck & Co. Inc., Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., Abcam PLC, Active Motif Inc., Diagenode Inc.

North America was the largest region in the women’s health devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the women’s health devices market report during the forecast period. The regions covered in the women’s health devices industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the women’s health devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The women’s health devices market consists of sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics/gynecology biopsy and imaging. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.